Marc, founding CEO of Antabio, is a molecular microbiologist and a bacterial geneticist with over 25 years’ experience in academia and biotech. Prior to founding Antabio, Marc held different research positions at various institutions globally such as CNRS and Inserm (France), CSIC (Spain) and Emory University (USA), authoring over 25 peer-reviewed articles in the field of bacterial pathogenesis and antibiotic resistance. Under Marc’s leadership, Antabio has raised high double-digit million funding and received numerous awards including CARB-X, the Wellcome Trust (twice), and the EIC Accelerator. Marc is a co-founder and a former Board member of the BEAM Alliance (European Alliance of Biopharmaceutical companies combating Anti-Microbial resistance), as well as a member of the SAB of JPIAMR (the Joint Programming Initiative on Antimicrobial Resistance).
